American drugmaker Regeneron's Otarmeni can restore natural hearing in children born deaf due to a genetic mutation ...
Morning Overview on MSN
FDA approves Regeneron’s first gene therapy for inherited deafness in children
When the parents of a toddler born profoundly deaf learned their child carried mutations in both copies of the OTOF gene, a ...
The US Food and Drug Administration (FDA) has approved lunsotogene parvec-cwha (Otarmeni), the first gene therapy for genetic ...
The FDA granted accelerated approval to lunsotogene parvec (Otarmeni) as the first gene therapy for genetic hearing loss, the ...
Supported by the CHORD trial, this AAV vector-based therapy delivers a working copy of the OTOF gene and restores otoferlin ...
The FDA has granted an accelerated approval for Otarmeni (lunsotogene parvec-cwha), the first gene therapy to treat patients ...
Morning Overview on MSN
Gene therapy restored hearing in 90% with OTOF deafness, study says
A single injection into the inner ear restored functional hearing in 90% of people born deaf because of mutations in the OTOF ...
Researchers mapped brain-wide astrocyte networks that link distant regions, proving these "support cells" have their own long ...
Dr. Purodha Prasad, ENT Specialist (Otolaryngologist) in Delhi & founder of Vanya Clinic, Aesthetics & ENT, recently treated ...
A 2026 informational overview of EchoXen ear drops, including the 18-ingredient hearing-support formulation, how the product ...
A North Lincolnshire woman is taking on the London Marathon to mark her 50th birthday while raising funds and awareness for ...
Elevating the importance of neural health via better diagnosis and treatment is crucial for restoration of natural hearing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results